IL1B and atherosclerosis: Yuan et al. (2020) revealed that IL-1β-containing EVs isolated from atherogenic-stimulated ECs induced the phenotypic transition of VSMC to synthetic phenotypes, promoting VSMC proliferation and migration and the pathophysiological process associated with neointima formation in atherosclerosis [32].